Pharmaceutical composition for preventing or treating rheumatoid arthritis comprising phenethyl cinnamamide derivative compound as active ingredient
AssigneeKnu-Industry Cooperation Foundation
InventorKoo Yeon LEE
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a pharmaceutical composition for preventing or treating rheumatoid arthritis, comprising a phenethyl cinnamide derivative compound as an active ingredient. The cannabinoid derivative compound may be effectively used in related industries by confirming effects of reducing an in vivo rheumatoid arthritis clinical index in a mouse model induced with rheumatoid arthritis, inhibiting damage to articular tissue, and reducing CII IgG antibody production in mouse serum.
Claims12
A compound represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof:
A pharmaceutical composition for preventing or treating rheumatoid arthritis, comprising a compound represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient
A food composition for preventing or alleviating rheumatoid arthritis, comprising a compound represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient
Dependencies are inferred from the claim text.